JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

J.P. Morgan’s U.S. equity research analysts compiled their list of “most compelling structural and tactical short ideas” for ...

Wall Street analysts are often criticized for being preternaturally upbeat. Buy ratings for top companies are abundant, and ...

Investing.com -- J.P. Morgan has named AngloGold Ashanti its top pick among EMEA gold miners, replacing Fresnillo (LON: FRES ...

Aegle Therapeutics, a clinical-stage dermatology-focused biopharmaceutical company developing novel therapies for those ...

Island, the Enterprise Browser company, announced the participation of J.P. Morgan Private Capital's Growth Equity Partners as a strategic investor in its previously announced Series E funding round.

Telix Pharmaceuticals shares have one of the best 5 year track records on the ASX. Can this continue according to JP Morgan?

JP Morgan maintains its Overweight rating on Vedanta Resources despite governance concerns raised by a third-party report.

JPMorgan said investment banking fees rose 7%, defying Wall Street projections and tariff woes. It's the first big bank to ...

Despite the allegations levelled by US-based Viceroy Research, JP Morgan maintained its Overweight stance on Vedanta bonds, ...